Announced on its homepage: “HEMARINA raises $ 3.7 Millions Serie B to pursuit its development and for the launching of several major brakthrough innovating products …”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
Hemarina is a biotechnology company developing a revolutionary oxygen carrier. Hemarina is a biotechnology company funded in 2007 by Dr. Franck Zal, in Brittany, France. Hemarina's main office is in M
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingHEMARINA the first universal oxygen carrier for therapeutic purposes
HEMARINAthe first universal oxygen carrier for therapeutic purposes Read more Institutional video “LEARN FROM NATURE: THAT IS WHERE OUR FUTURE... Lire la suite
July 2022 – July 2026 · 3 capturesHEMARINA le 1er transporteur d’oxygène universel à visée thérapeutique
HEMARINA le 1er transporteur d’oxygène universel à visée thérapeutique En savoir + Vidéo institutionnelle « Scrute la nature, c’est là... Lire la suite